Efficacy and safety of low-dose prophylaxis of highly purified plasma-derived factor VIII concentrate produced by the National Blood Centre, Thai Red Cross Society-Reference-Cited by-同舟云学术

Efficacy and safety of low-dose prophylaxis of highly purified plasma-derived factor VIII concentrate produced by the National Blood Centre, Thai Red Cross Society

Published:2018-08-17 Issue:5 Volume:24 Page:e387-e390
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Chuansumrit Ampaiwan¹^ORCID,Sosothikul Darintr²^ORCID,Natesirinilkul Rungrote³^ORCID,Lektrakul Yujinda⁴^ORCID,Charoonruangrit Ubonwon⁵^ORCID,

Affiliation:

1. Department of Pediatrics; Faculty of Medicine; Ramathibodi Hospital; Mahidol University; Bangkok Thailand

2. Department of Pediatrics; Faculty of Medicine; King Chulalongkorn Memorial Hospital; Chulalongkorn University; Bangkok Thailand

3. Department of Pediatrics; Faculty of Medicine; Chiang Mai University; Chiang Mai Thailand

4. Division of Pediatrics; Sappasitthiprasong Hospital; Ubon Ratchathani Thailand

5. The National Blood Centre; Thai Red Cross Society; Bangkok Thailand

Funder

Thai Society of Hematology

International Hemophilia Training Center-Bangkok

Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.13601/fullpdf

Reference10 articles.

1. Guidelines on viral inactivation and removal procedures intended to assure the viral safety of human blood plasma products 2004

2. Dry-heat treatment process for enhancing viral safety of an antihemophilic factor VIII concentrate prepared from human plasma;Kim;J Microbiol Biotechnol,2008

3. European Pharmacopoeia 2013

4. Guideline on plasma derived medicinal products

5. Guideline on core SmPC for human plasma derived and recombinant coagulation factor VIII products

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practices and challenges for hemophilia management under resource constraints in Thailand;Orphanet Journal of Rare Diseases;2023-05-10

2. A Comparison of the Incidence Rate for Joint Bleeding and FVIII Consumption between On-Demand versus Prophylaxis Factor VIII Replacement Therapy and the Direct Cost of Prophylaxis Treatment in Severe Haemophilia A Patients;Malaysian Journal of Medical Sciences;2023-02-28

3. Prophylaxis is the new standard of care in patients with haemophilia;South African Medical Journal;2022-06-01

4. Low dose prophylaxis and antifibrinolytics: Options to consider with proven benefits for persons with haemophilia;Haemophilia;2022-05

5. Low‐dose prophylaxis and its impact on the health of haemophilia patients;Vox Sanguinis;2022-04-18